{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:27Z","timestamp":1760144127058,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"am","delay-in-days":404,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.rmr.2017.11.014","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:31:50Z","timestamp":1548401510000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["M\u00e9soth\u00e9liomes malins et mutations constitutionnelles du g\u00e8ne BAP1"],"prefix":"10.1016","volume":"36","author":[{"given":"Z.","family":"Neviere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Polycarpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dubos-Arvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"D\u00f4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2017.11.014_bib0180","first-page":"182","article-title":"Peritoneal mesothelioma: the site of origin matters","author":"Kindler","year":"2013","journal-title":"Am Soc Clin Oncol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canep.2014.02.014","article-title":"Familial malignant mesothelioma: a population-based study in central Italy (1980-2012)","volume":"38","author":"Ascoli","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0190","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1\u00a0mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Gene"},{"key":"10.1016\/j.rmr.2017.11.014_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1\u00a0and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.rmr.2017.11.014_bib0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1\u00a0interferes with BRCA1\/BARD1\u00a0RING heterodimer activity","volume":"69","author":"Nishikawa","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.rmr.2017.11.014_bib0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1\u00a0function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.rmr.2017.11.014_bib0210","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","article-title":"Gene of the month: BAP1","volume":"69","author":"Wang","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anndiagpath.2016.10.010","article-title":"Usefulness of p16\/CDKN2A fluorescence in situ hybridization and BAP1\u00a0immunohistochemistry for the diagnosis of biphasic mesothelioma","volume":"26","author":"Wu","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2016.09.026","article-title":"BAP1\u00a0immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma","volume":"60","author":"McGregor","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0225","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1\u00a0facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.21037\/jgo.2016.03.05","article-title":"BRCA-associated protein 1\u00a0mutant cholangiocarcinoma: an aggressive disease subtype","volume":"7","author":"Al-Shamsi","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/CMO.S15239","article-title":"The Importance of multidisciplinary approach in early detection of BAP1\u00a0tumor predisposition syndrome: clinical management and Risk Assessment","volume":"8","author":"Battaglia","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0240","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1309\/AJCPG8LFJC0DHDQT","article-title":"Loss of BAP1\u00a0expression in basal cell carcinomas in patients with germline BAP1\u00a0mutations","volume":"143","author":"Mochel","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1\u00a0tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.rmr.2017.11.014_bib0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1\u00a0mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.rmr.2017.11.014_bib0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/gcc.2870090114","article-title":"Deletion mapping of the short arm of chromosome 3\u00a0in human malignant mesothelioma","volume":"9","author":"Lu","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.rmr.2017.11.014_bib0260","first-page":"302","article-title":"Loss of expression of BAP1\u00a0predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology (Phila)"},{"key":"10.1016\/j.rmr.2017.11.014_bib0265","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1\u00a0is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1\u00a0mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.rmr.2017.11.014_bib0270","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1\u00a0heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.rmr.2017.11.014_bib0275","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1\u00a0mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.rmr.2017.11.014_bib0280","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/oem.2005.023200","article-title":"The French National Mesothelioma Surveillance Program","volume":"63","author":"Goldberg","year":"2006","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.rmr.2017.11.014_bib0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2\u00a0is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rmr.2017.11.014_bib0290","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2016.05.011","article-title":"CDKN2A and BAP1\u00a0germline mutations predispose to melanoma and mesothelioma","volume":"378","author":"Betti","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.rmr.2017.11.014_bib0295","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-16-0229","article-title":"Genomic Landscape of Malignant Mesotheliomas","author":"Kato","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.rmr.2017.11.014_bib0300","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1097\/MD.0000000000000773","article-title":"Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22\u00a0Chinese patients","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2017.11.014_bib0305","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1\u00a0predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.rmr.2017.11.014_bib0310","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1\u00a0in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.rmr.2017.11.014_bib0315","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1\u00a0inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw C-NJ","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.rmr.2017.11.014_bib0320","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1\u00a0mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.rmr.2017.11.014_bib0325","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/pcmr.12046","article-title":"Prevalence of germline BAP1\u00a0mutation in a population-based sample of uveal melanoma cases","volume":"26","author":"Aoude","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.rmr.2017.11.014_bib0330","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1\u00a0and SETD2\u00a0in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies","volume":"15","author":"Piva","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.rmr.2017.11.014_bib0335","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1\u00a0cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.rmr.2017.11.014_bib0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.annder.2014.09.606","article-title":"Recommendations pour le diagnostic de pr\u00e9disposition g\u00e9n\u00e9tique au m\u00e9lanome cutan\u00e9 et pour la prise en charge des personnes \u00e0 risque","volume":"142","author":"Avril","year":"2015","journal-title":"Ann Dermatol Venerol"},{"key":"10.1016\/j.rmr.2017.11.014_bib0345","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/gcc.22473","article-title":"Occurrence of BAP1\u00a0germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: a pilot study","volume":"56","author":"Cabaret","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.rmr.2017.11.014_bib0175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and phenotypic features of BAP1\u00a0cancer syndrome: a report of 8\u00a0new familie and review of cases in the literature","volume":"153","author":"Haugh","year":"2017","journal-title":"JAMA Dermatol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518309707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518309707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:18:33Z","timestamp":1760105913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518309707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0761842518309707"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.014","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9soth\u00e9liomes malins et mutations constitutionnelles du g\u00e8ne BAP1","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}